Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-48
Closed -$786 950
2025
Q4
$786 Sell
48
-156
-76% -$2.75K ﹤0.01% 797
2025
Q3
$3.83K Hold
204
﹤0.01% 753
2025
Q2
$4.12K Hold
204
﹤0.01% 780
2025
Q1
$2.81K Hold
204
﹤0.01% 839
2024
Q4
$2.42K Hold
204
﹤0.01% 841
2024
Q3
$3.66K Hold
204
﹤0.01% 833
2024
Q2
$3.59K Hold
204
﹤0.01% 883
2024
Q1
$5.24K Hold
204
﹤0.01% 801
2023
Q4
$5.32K Hold
204
﹤0.01% 818
2023
Q3
$4.7K Hold
204
﹤0.01% 833
2023
Q2
$4.79K Hold
204
﹤0.01% 861
2023
Q1
$2.42K Hold
204
﹤0.01% 962
2022
Q4
$3.13K Hold
204
﹤0.01% 943
2022
Q3
$4K Hold
204
﹤0.01% 905
2022
Q2
$4K Hold
204
﹤0.01% 895
2022
Q1
$6K Hold
204
﹤0.01% 829
2021
Q4
$6K Buy
+204
New +$6.64K ﹤0.01% 834

Other funds holding XP

Investors Research Corp's XP Position: Q1 2026 in Review

Investors Research Corp sold out of XP (XP) in Q1 2026, closing a stake of 48 shares — an estimated $786 sold.

Investors Research Corp first reported a position in XP in Q4 2021 and held it in 17 quarters. The position peaked at $6K in Q1 2022. 359 funds tracked by Wall St. Rank hold XP as of Q1 2026.

  • Investors Research Corp reported no remaining XP position as of Q1 2026 after selling out during the quarter.
  • Investors Research Corp sold 48 XP shares in Q1 2026, an estimated $786.
  • Investors Research Corp first reported a position in XP in Q4 2021 and held it in 17 quarters.
  • Investors Research Corp's XP position peaked at $6K in Q1 2022.
  • 359 funds tracked by Wall St. Rank held XP as of Q1 2026.

Based on Investors Research Corp's 13F filing for Q1 2026, filed 3 Apr 2026.